期刊文献+

脑转移瘤的磁共振成像新进展 被引量:11

New advances in magnetic resonance imaging of brain metastasis
下载PDF
导出
摘要 脑转移瘤(BM)的生长需要适宜的微环境,而正常脑微环境的改变是MR探查BM的基础。利用局部磁场的变化,外加对比剂人为提高组织的差异,MR可准确发现脑转移瘤发生的部位、大小、数目和形态,而MR增强检查是诊断脑转移瘤的首选方法。各种MR新成像技术、扫描序列以及新型细胞内对比剂的应用,不仅可以进一步提高瘤灶检出率,还可提高敏感性,有利于制定合理的治疗方案,延长生存期。本文综述脑转移瘤的微环境、磁共振成像新技术方面的研究进展。 The growth of brain metastasis needs appropriate microenvironment,and the change of normal brain microenvironment is the basis for exploring metastasis with MRI.Through the local magnetic field changes and the application of contrast agents for improving the discrepancy of the cerebral tissue,MR can accurately detect brain metastasis in position,number,size,and shape.MR with contrast-enhanced technique is the first choice for screening brain metastasis.The application of all kinds of new MR techniques,sequences and intracellular contrast agents can not only further improve the specificity of detection,but also improve the sensitivity of MRI,which is favorable to formulating reasonable treatment and prolonging the lifetime of the patients.The microenvironment of brain metastasis and advances in the new MR techniques were reviewed in this article.
出处 《中国医学影像技术》 CSCD 北大核心 2009年第12期2306-2308,共3页 Chinese Journal of Medical Imaging Technology
基金 上海市科委重点项目(07jc14032) 上海市卫生局青年科研项目(2008Y108)
关键词 脑肿瘤 肿瘤转移 磁共振成像 Brain neoplasms Neoplasm metastasis Magnetic resonance imaging
  • 相关文献

参考文献21

  • 1Soffietti R, Rudd R, Mutani R. Management of brain metastases. J Neurol, 2002,249(10) : 1357-1369.
  • 2Nathoo N, Chahlavi A, Barnett GH, et al. Pathobiology of brain metastases. J Clin Pathol, 2005,58(3) :237-242.
  • 3Fayed N, Ddvila J, Medrano J, et al. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Eur J Radiol, 2008,67(3):427 -433.
  • 4Velicu S, Han Y, Ulasov I, et al. Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effeetor phase but can be augmented with local immunotherapy. J Neuroimmunol, 2006,174(1-2) :74-81.
  • 5Weil RJ, Palmieri DC, Bronder JL, et al. Breast cancer metastasis to the central nervous system. Am J Pathol, 2005, 167(4):913- 920.
  • 6Grosshans DR, Meyers CA, Allen PK, et al. Neurocognitive function in patients with small cell lung cancer: effect of prophylactic cranial irradiation. Cancer, 2008,112(3):589-595.
  • 7Samlowski WE, Watson GA, et al. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer, 2007,109(9) :1855-1862.
  • 8Komada T, Naganawa S, Ogawa H, et al. Contrast-enhanced MRI imaging of metastatic brain tumor at 3 tesla: utility of T(1) weigh ted SPACE compared with 2D spin echo and 3D gradient echo sequence. Mag Res Med Sci, 2008,7(1):13-21.
  • 9Ishimaru H, Morikawa M, Iwanaga S, et al. Differentiation between high-grade glioma and metastatic brain tumor using single voxel proton MR spectroscopy. Eur Radiol, 2001, 11 (9) : 1784-1791.
  • 10Opstad KS, Griffiths JR, Bell BA, et al. Apparent T(2)relaxation times of lipid and macromolecules: a study of high-grade tumor spectra. J Magn Reson Imaging, 2008,27(1) : 178-184.

二级参考文献10

  • 1Vecht CJ. Clinical management of brain metastases. J Neurol, 1998,245(3) : 127-131.
  • 2Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Eng J Med, 1990,322(8) :494 500.
  • 3Earnest F 4th, Ryu JH, Miller GM, et al. Suspected Non small cell lung cancer: Incidence of occult brain and skeletal metastases and effectiveness of imaging for detection-Pilot study. Radiology, 1999,211 (1) : 137-145.
  • 4Runge VM, Wells JW, Nelson KL, et al. MR imaging detection of cerebral metastases with a single injection of high-dose gadoteridol. J Magn Reson Imaging, 1994,4(5):669-673.
  • 5Haustein J, Laniado M, Niendorf HP, et al. Triple dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients. Radiology, 1993, 186(3) :855- 860.
  • 6Delattre JY. Krol G, Thaler HA, et al. Distribution of brain metastases. Arch Neurol, 1988,45(7) :741-744.
  • 7Kirchin M, Pirovano G, Spinazzi A. Gadobenate dimeglumine(GdBOPTA) : an overview. Invest Radiol, 1998,33(11) :798-809.
  • 8Schneider G, Kirchin MA, Pirovano G, et al. Gadobenate dimeglumine enhanced magnetic resonance imaging of intracranial metastases: effect of dose on lesion detection and delineation. J Magn Reson Imaging, 2001,14(5) :525-539.
  • 9Baleriaux D, Colosimo C, Ruscalleda J, et al. Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine. Ncuroradiology, 2002,44(3) : 191-203.
  • 10Knopp MV, Runge VM, Essig M, et al. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of Gadobenate dimeglumine and Gadopentetate dimegluminel, Radiology, 2004,230( 1 ) : 55-64.

共引文献16

同被引文献118

引证文献11

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部